Evidence map›Paper›PMID 32059523›Full record

ArticleMolecules (Basel, Switzerland)2020

Two New Apotirucallane-Type Triterpenoids from the Pericarp of

Di Liu, Rong-Shen Wang, Lu-Lu Xuan, Xiao-Hong Wang, Wan-Zhong Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Terpenoids from the Seeds ofMolecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Di LiuSchool of Pharmacy, Weifang Medical University, Weifang 261053, Shandong Province, China.
Rong-Shen WangSchool of Pharmacy, Weifang Medical University, Weifang 261053, Shandong Province, China.
Lu-Lu XuanSchool of Pharmacy, Weifang Medical University, Weifang 261053, Shandong Province, China.
Xiao-Hong WangSchool of Pharmacy, Weifang Medical University, Weifang 261053, Shandong Province, China.
Wan-Zhong LiSchool of Pharmacy, Weifang Medical University, Weifang 261053, Shandong Province, China.
Weifang Medical University · CN

Funding

National Nature Science Foundation of China 81274049Natural Science Foundation of Shandong Province ZR2018MH040Shandong Science and Technology Research Project of Traditional Chinese Medicine 2015227Staring Foundation for Doctorate Research of Weifang medical university 2017BSQD50
6 · The paper itself

Abstract

Hyperglycemia is a strong risk factor for chronic complications of diabetes. Hyperglycemic conditions foster not only the production of reactive oxygen species (ROS), but also the consumption of antioxidants, leading to oxidative stress and promoting the occurrence and progression of complications. During our continuous search for antioxidant constituents from the pericarp of

Indexed as

AnimalsCell Culture TechniquesDiabetic NephropathiesGlucoseHumansMeliaceaeMesangial CellsOxidative StressRatsReactive Oxygen SpeciesSuperoxide DismutaseTriterpenesapotirucallaneGlucoseReactive Oxygen SpeciesSuperoxide DismutaseTriterpenesapotirucallane-type triterpenoidcycloartane-type triterpenoidoxidative stressrat glomerular mesangial cellsToona sinensis (A. Juss.) Roem

Identifiers

PMID32059523
PMCPMC7070558
OpenAlexW3006049068

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.